Boothbay Fund Management LLC Takes Position in Mettler-Toledo International Inc. (NYSE:MTD)

Boothbay Fund Management LLC purchased a new position in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 240 shares of the medical instruments supplier's stock, valued at approximately $294,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Alliancebernstein L.P. boosted its holdings in Mettler-Toledo International by 9.9% during the fourth quarter. Alliancebernstein L.P. now owns 583,181 shares of the medical instruments supplier's stock valued at $713,627,000 after acquiring an additional 52,726 shares during the period. Geode Capital Management LLC grew its stake in shares of Mettler-Toledo International by 2.0% in the fourth quarter. Geode Capital Management LLC now owns 558,471 shares of the medical instruments supplier's stock worth $682,340,000 after acquiring an additional 11,032 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in Mettler-Toledo International by 6.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 455,739 shares of the medical instruments supplier's stock worth $557,680,000 after acquiring an additional 25,873 shares during the period. T. Rowe Price Investment Management Inc. raised its stake in Mettler-Toledo International by 36.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier's stock valued at $444,327,000 after purchasing an additional 96,300 shares during the last quarter. Finally, Norges Bank bought a new stake in Mettler-Toledo International in the 4th quarter valued at $372,954,000. Institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Stock Up 1.8 %

Shares of NYSE:MTD traded up $19.79 during trading on Thursday, reaching $1,104.25. 46,081 shares of the company traded hands, compared to its average volume of 146,436. The firm has a market capitalization of $23.01 billion, a PE ratio of 27.25, a PEG ratio of 3.30 and a beta of 1.40. The company's 50 day moving average is $1,125.26 and its two-hundred day moving average is $1,227.33. Mettler-Toledo International Inc. has a 52 week low of $946.69 and a 52 week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, topping analysts' consensus estimates of $7.90 by $0.29. The business had revenue of $883.74 million for the quarter, compared to analyst estimates of $876.61 million. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Mettler-Toledo International's quarterly revenue was down 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $8.89 EPS. As a group, research analysts anticipate that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the firm's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the transaction, the insider now owns 6 shares in the company, valued at $8,108.04. This trade represents a 99.01 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Christian Magloth sold 790 shares of the company's stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the sale, the insider now directly owns 734 shares in the company, valued at $964,248.46. This trade represents a 51.84 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several analysts have recently commented on MTD shares. StockNews.com cut Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday. Evercore ISI raised their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a report on Monday, February 10th. Jefferies Financial Group upgraded Mettler-Toledo International from an "underperform" rating to a "hold" rating and lowered their price objective for the stock from $1,200.00 to $1,110.00 in a research report on Monday. Wells Fargo & Company raised their price target on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research report on Monday. Finally, Robert W. Baird lowered their target price on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research note on Tuesday, April 22nd. Seven investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International presently has an average rating of "Hold" and an average price target of $1,296.13.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.